- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-568/22: Order of the General Court of 8 June 2023 — XNT v EUIPO — Exane (EXANE) (EU trade mark — Invalidity proceedings — EU word mark EXANE — Earlier company name EXANTE — Domain name ‘exante.eu’ — Relative ground for invalidity — Article 8(4) and Article 53(1)(c) of Regulation (EC) No 207/2009 (now Article 8(4) and Article 60(1)(c) of Regulation (EU) 2017/1001) — Action manifestly lacking any foundation in law)
ECLI:EU:UNKNOWN:62022TB0568
62022TB0568
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 252/49
(Case T-568/22) (<span class="oj-super oj-note-tag">1</span>)
(EU trade mark - Invalidity proceedings - EU word mark EXANE - Earlier company name EXANTE - Domain name ‘exante.eu’ - Relative ground for invalidity - Article 8(4) and Article 53(1)(c) of Regulation (EC) No 207/2009 (now Article 8(4) and Article 60(1)(c) of Regulation (EU) 2017/1001) - Action manifestly lacking any foundation in law)
(2023/C 252/59)
Language of the case: French
Parties
Applicant: XNT ltd. (St. Julian’s, Malta) (represented by: A. Renck, C. Stöber and M.-A. de Dampierre, lawyers)
Defendant: European Union Intellectual Property Office (represented by: C. Bovar and D. Hanf, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Exane (Paris, France) (represented by: C.-A. Joly, lawyer)
Re:
By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 14 June 2022 (Case R 2093/2020-2).
Operative part of the order
1.The action is dismissed.
2.XNT ltd. shall bear its own costs and pay those incurred by Exane.
3.The European Union Intellectual Property Office (EUIPO) shall bear its own costs.
(<span class="oj-super">1</span>) OJ C 418, 31.10.2022.